Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
LAURUSLABS Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
High and improving ROE
High and improving operating margin
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
LAURUSLABS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
LAURUSLABS Bulk, Block & Insider Trades
LAURUSLABS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Stock split(1 : 5)Nominal value change from INR 10 to INR 2 Ex-date: 29th Sep 2020 Announced on: 30th Apr 2020
Company Profile
Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company offers an integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical... Read More
Key personnel
Dr. Ravindranath KancherlaD
Non-Executive Independent Chairman of the Board
Dr. Satyanarayana Chava, Ph.D.D
Chief Executive Officer, Executive Director
Mr. Venkata Ravi Kumar VantaramD
Chief Financial Officer, Executive Director
Dr. V. Uma Maheswer Rao
President Chemical R and D
Mr. Srinivasa Rao Suryadevara
President - Manufacturing and Operations
Mr. Thomas Versosky
President - FDF, North America
Mr. Jyothi Basu Abbibeni
Executive Vice President - Chemical R and D
Mr. Narasimha Rao Chava
Executive Vice President - Human Resources
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Laurus Labs Ltd.?
The current share price of Laurus Labs Ltd. is ₹ 1,082.65 as of 09 Jan 2026.
What is the PE ratio of Laurus Labs Ltd.?
The Price-to-Earnings (PE) ratio of Laurus Labs Ltd. is 85.45 as of the latest financial data.
What is the ROE and ROCE of Laurus Labs Ltd.?
Laurus Labs Ltd. has a Return on Equity (ROE) of 15.30% and a Return on Capital Employed (ROCE) of 14.74% as per the latest financial reports.
What is the market cap of Laurus Labs Ltd.?
The market capitalization of Laurus Labs Ltd. stands at ₹ 58,447.60 Cr.
What is the dividend yield of Laurus Labs Ltd.?
The dividend yield of Laurus Labs Ltd. is 0.11% based on the current market price.
What is the RSI of Laurus Labs Ltd.?
The Relative Strength Index (RSI) of Laurus Labs Ltd. is 56.28.
What is the FII and DII holding in Laurus Labs Ltd.?
Foreign Institutional Investors (FII) hold 26.17% and Domestic Institutional Investors (DII) hold 10.29% of Laurus Labs Ltd. shares.
What sector does Laurus Labs Ltd. belong to?
Laurus Labs Ltd. operates in the Healthcare sector.
What is the beta of Laurus Labs Ltd. stock?
The beta of Laurus Labs Ltd. stock is 1.26, indicating its volatility relative to the broader market.
